{
    "title": "GlaxoSmithKline signs partnership worth more than \u00a3209m with Adaptimmune to develop cancer drugs based on cell therapies",
    "url": "https://www.dailymail.co.uk/money/markets/article-2646398/GlaxoSmithKline-signs-partnership-worth-209m.html",
    "date": "2014-06-02",
    "keywords": [
        "cancer",
        "glaxosmithkline",
        "partnership",
        "adaptimmune",
        "cell",
        "deal",
        "sign",
        "drug",
        "maker",
        "programme",
        "development",
        "mail",
        "gmt",
        "june",
        "email",
        "view",
        "activity",
        "pharma",
        "sector",
        "investigation",
        "fraud",
        "office",
        "bribery",
        "china",
        "gsk",
        "commercialisation",
        "executive",
        "sir",
        "favour",
        "bolton",
        "biotech",
        "blood",
        "asset",
        "swap",
        "rival",
        "novartis",
        "consumer",
        "healthcare",
        "astrazeneca",
        "takeover",
        "proposal",
        "predator",
        "pfizer",
        "market",
        "host",
        "medicinesdrug",
        "patent",
        "cliff",
        "protection",
        "copycats"
    ],
    "category": [
        "money",
        "markets"
    ]
}